Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Early seizures after epilepsy surgery predict more seizures

24.01.2005


The prevailing medical understanding of seizures in the weeks just after epilepsy surgery is that they are likely to be temporary, probably due to swelling or minor trauma suffered by the brain during the operation.

In fact, early seizures after the most common form of epilepsy surgery signal a greatly increased likelihood that the patient will continue to have seizures, according to a study published online January 24, 2005, in the Annals of Neurology (http://www.interscience.wiley.com/journal/ana).

"These findings have implications for patient counseling, but they are also interesting in terms of understanding epilepsy," said lead author Anne M. McIntosh, Ph.D., of the University of Melbourne in Australia. "We can speculate that some individuals who undergo this procedure have epilepsy that for some reason is more persistent."



There have been hints from smaller studies that early seizures following surgery are not all benign, but the Melbourne study, with 325 patients who underwent temporal lobe removal (lobectomy), is the largest to date. Temporal lobectomy is the most common form of epilepsy surgery, targeting the area where seizures commonly begin. It eliminates or reduces seizures in most cases.

McIntosh and colleagues found that patients who experienced a seizure in the four weeks following surgery -- in the absence of surgery-related triggers such as trauma or swelling -- were eight times more likely to have persistent epilepsy several months later. Even among the patients with evidence of these seizure triggers there was a three-fold increase in the likelihood of continuing epilepsy.
Given that surgery is only performed in cases where the disease is debilitating, these results do not cast doubt on the procedure itself. "Many subjects who have a return of epilepsy still have ongoing benefit from the procedure in terms of reduced seizure frequency," said McIntosh.

Epilepsy is a chronic illness of the brain that is estimated to affect one percent of the U.S. population -- about 2.5 million people. During an epileptic seizure, nerve cells in the brain fire electrical impulses much faster than normal, often leading to muscular convulsions or loss of consciousness.

Many epilepsy patients can be successfully treated with medications that prevent the formation of the "electrical storms" in the brain that cause seizures. "About 20 percent of patients have epilepsy that does not respond to medication, and perhaps a third of these may be suitable for surgery," said McIntosh. This is particularly true of temporal lobe epilepsy, where seizures begin in the temporal lobe of the brain and spread to other regions.

Others authors of the study were Renate M. Kalnins, FRACP, Anne Mitchell, PRACR, and Samuel F. Berkovic, MD.

David Greenberg | EurekAlert!
Further information:
http://www.interscience.wiley.com/journal/ana
http://www.aneuroa.org
http://www.wiley.com

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

Im Focus: A molecular switch may serve as new target point for cancer and diabetes therapies

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. The results of the study have just been published in the prestigious scientific journal 'Molecular Cell'.

Cell growth and cell differentiation as well as the release and efficacy of hormones such as insulin depend on the presence of lipids. Lipids are small...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

NRL's sun imaging telescopes fly on NASA Parker Solar Probe

13.08.2018 | Physics and Astronomy

UT-ORNL team makes first particle accelerator beam measurement in six dimensions

13.08.2018 | Physics and Astronomy

ASU astrophysicist helps discover that ultrahot planets have starlike atmospheres

13.08.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>